AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies.
AlveoliX AG has raised $1.2M in total funding. The most recent round was Grant. The last funding was announced in June 2026.
AlveoliX AG's investors include The Vijay and Marie Goradia Charitable Foundation, Eurostars.
AlveoliX AG is headquartered in Berne, Switzerland.
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies.
AlveoliX AG is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AlveoliX AG — Funding & Investors." VCBacked, June 10, 2026, https://www.vcbacked.co/company/alveolix-ag. Accessed September 30, 2026.
VCBacked. (2026). AlveoliX AG — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/alveolix-ag
{{cite web |title=AlveoliX AG — Funding & Investors |url=https://www.vcbacked.co/company/alveolix-ag |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated